Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Based on: 10-K (reporting date: 2022-01-29), 10-K (reporting date: 2021-01-30), 10-K (reporting date: 2020-02-01), 10-K (reporting date: 2019-02-02), 10-K (reporting date: 2018-02-03), 10-K (reporting date: 2017-01-28).
The analysis of the financial data over the six-year period reveals several notable trends and fluctuations in key financial metrics.
- Net Sales
- There is a consistent upward trend in net sales, rising from approximately $20.7 billion in early 2017 to $26.3 billion by early 2022. This indicates steady revenue growth over the years.
- Cost of Sales
- Cost of sales has also increased steadily, from about $14.3 billion in 2017 to $18.6 billion in 2022. The increase follows a similar trajectory as net sales, suggesting that cost management remained proportionate to sales growth.
- Gross Profit
- Gross profit saw growth from roughly $6.4 billion in 2017, peaking near $7.8 billion in 2021, before a slight decline to $7.7 billion in 2022. While generally increasing, the gross profit margin may have experienced some compression in the most recent year.
- Other Revenue
- This category shows negligible or no reported amounts until 2021 and 2022, where it registers at $900 thousand and $11.4 million respectively, indicating a new or expanded revenue source during these years.
- Selling, General and Administrative Expenses (SG&A)
- Excluding impairments, SG&A expenses steadily increased from about $4.7 billion in 2017 to $5.9 billion in 2022. The inclusion of goodwill and receivable impairments dramatically impacted total SG&A expenses in 2019 and 2020, with a peak of nearly $7.9 billion in 2019, driven mainly by a significant $2.7 billion goodwill impairment in 2019 and an additional impairment in preceding years.
- Operating Income (Loss)
- Operating income rose from $1.7 billion in 2017 to a peak of about $2 billion in 2018, followed by a sharp loss of approximately $940 million in 2019 correlating with large impairments that year. It recovered strongly in 2020, reaching $1.3 billion, and continued improving slightly through 2021 and 2022, maintaining around $1.8 billion.
- Interest Expense, Net
- Interest expense fluctuated modestly, declining from $375 million in 2017 to a low of $147 million in 2021 before rising slightly to $179 million in 2022. This suggests manageable debt costs with some variability over the years.
- Other Income (Expense), Net
- Other income and expenses show small fluctuations with minor positive and negative values, peaking at $6.7 million in 2018 and slightly negative values in later years, indicating minimal impact on profitability.
- Income Before Income Taxes
- This metric follows a pattern similar to operating income—rising from $1.3 billion in 2017 to $1.7 billion in 2018, falling sharply to a loss of about $131 million in 2019, then recovering to approximately $1.7 billion by 2021 and slightly decreasing to $1.6 billion in 2022.
- Provision for Income Taxes
- The provision for income taxes shows an unusual positive value in 2018 ($10.3 million) amidst otherwise negative expenses, possibly reflecting tax benefits or adjustments. For other years, it generally increases in absolute terms up to $398 million in 2021 and then declines somewhat in 2022, consistent with the fluctuations in pre-tax income.
- Net Income (Loss)
- Net income rose significantly from $896 million in 2017 to $1.7 billion in 2018, followed by a substantial loss of $1.6 billion in 2019 aligning with impairments recorded. Subsequently, net income returned to positive territory, reaching $1.3 billion in 2021 and remaining stable in 2022 at approximately $1.3 billion.
Overall, the data reflect steady revenue growth and generally increasing gross profits, tempered by significant one-time impairments in 2019 and some variability in operating profit and net income aligned with these non-recurring charges. Expenses excluding impairments grew steadily, indicating controlled operational spending relative to growth. The company returned to profitability after a challenging year in 2019, demonstrating resilience in its core operations.